Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. General Cardiovascular Medicine
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1402137
This article is part of the Research Topic Challenges and Future Perspectives of Transcatheter Valve Interventions View all 6 articles

Occlusion of functional high-volume intra-atrial shunts in older patients after embolic stroke of undetermined source

Provisionally accepted
Helene Schrader Helene Schrader 1Leif-Hendrik Boldt Leif-Hendrik Boldt 1Abdul Shokor Parwani Abdul Shokor Parwani 1Florian Blaschke Florian Blaschke 1Julia M. Wiedenhofer Julia M. Wiedenhofer 1Tobias D. Trippel Tobias D. Trippel 1Gerhard Hindricks Gerhard Hindricks 1Christoph Starck Christoph Starck 2Henryk Dreger Henryk Dreger 1Mohammad Sherif Mohammad Sherif 1Uwe Primessnig Uwe Primessnig 1*
  • 1 Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center Berlin, Berlin, Baden-Württemberg, Germany
  • 2 Department for Cardiovascular and Thoracic Surgery, German Heart Center Berlin, Berlin, Baden-Württemberg, Germany

The final, formatted version of the article will be published soon.

    Background: Intra-atrial shunts are associated with an elevated risk for embolic stroke of undetermined source (ESUS). Percutaneous occluder implantation is recommended as secondary prevention in younger patients. This study aims to compare the outcome after shunt occlusion between younger and older patients with a history of presumed paradox embolism and evaluate the impact of high-volume shunting in an elderly population.We performed a single-centre, retrospective, observational study and included 187 patients, that underwent interventional percutaneous PFO or ASD occlusion between 2013 and 2023 at our centre.Results: Mean age was 51.8±11.8 years with 76 patients in the age group < 50 years and 111 patients in age group > 50 years. Older patients had more cardiovascular risk factors. Presence of atrial septum aneurysm or large shunting was evenly distributed (ASA 26.3% vs. 28.8%, p=0.833, mean shunt defect size 6.67 vs. 7.23 mm, p=0.151). There were no differences in procedural or intrahospital complications. Event rate during 6-month follow up was low.Recurrence of arterial embolism occurred in 1.6% of the younger and 3.8% of the older patients (p=0.817). Comparing high volume shunts (defect size > 10 mm or passage > 20 bubbles during bubble study) with low volume shunts in this elderly cohort with a mean age > 50 years, showed no significant difference regarding the outcome. There was a statistically non-significant trend towards a higher rate of residual shunt at the end of the procedure in the high volume shunt group (2.9% vs. 9.8%, p=0.0894). This difference could not be seen at the 6 months follow up anymore (14.5 vs. 12.1%, p=0.628). Two unsuccessful implantation attempts were reported in the high volume shunt group, while none was observed in the low volume shunt group (p=0.372). No intervention related deaths occurred in this patient cohort during follow up.Occlusion of relevant, intra-atrial shunting is a safe and effective option for secondary prevention of cryptogenic embolism in patients >50 years of age. Beneficial outcome was irrespective of a high volume shunting before implantation.

    Keywords: Patent foramen ovale (PFO), atrial septum defect (ASD), paradox embolism, Transcatheter occlusion, Embolic stroke of Undetermined Source (ESUS)

    Received: 16 Mar 2024; Accepted: 28 Aug 2024.

    Copyright: © 2024 Schrader, Boldt, Shokor Parwani, Blaschke, Wiedenhofer, Trippel, Hindricks, Starck, Dreger, Sherif and Primessnig. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Uwe Primessnig, Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center Berlin, Berlin, 13353, Baden-Württemberg, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.